The Use of High-energy Digestible Food in Women Undergoing Caesarean Section

Traditionally, Fasting for more than 8 hours before operation is administered to reduce the risk of reverse flow and aspiration. ASA guidelines suggest a 2-hour fasting for clear fluid in healthy people before elective surgery. But in delivery women, the gastric emptying time is affected by the physiological change. This study is a prospective randomized controlled study to investigate the gastric emptying time of high energy digestible foods in delivery women, and the effect of high energy digestible food given before surgery on the comfort and metabolism of women undergoing Cesarean section. In the first step, 60 women in delivery room whose gastric volume less than 3.81 cm2 are randomly divided into three groups, 20 cases in each group. The experimental group (Group E1) is treated with high energy digestible food 300ml, Group G1 is given 5% glucose injection 300ml and Group N1 is given normal saline 300ml. The gastric volume was determined by ultrasonography once every hour until gastric volume less than 3.81cm2, and the time of gastric emptying was determined. The second step was to recruit 80 cases of full-term elective cesarean section. They were randomly divided into four groups, 20 cases in each group. The experimental group (Group E2) was given high energy digestible food 300ml before the time of gastric emptying found in the first step , Group G2 is given 5% glucose injection 300ml and Group N2 is given normal saline 300ml, while the control group (Group C2) was not given any diet. After admission to the operation room, the volume of the stomach was measured by ultrasound, and the differences of comfort, body temperature, shivering, blood glucose and postoperative anal exhaust time between the two groups were observed. This study is going to investigate the gastric emptying time of high energy digestible foods in delivery women, and the effect of high energy digestible food on the comfort, body temperature and blood glucose of women undergoing Cesarean section, so as to provide a good basis for reducing the surgery stress in women undergoing Cesarean section.

Study Overview

• Status: Unknown
• Conditions: Caesarean Section
• Intervention / Treatment: Dietary supplement: high-energy digestible food E2; Dietary supplement: glucose injection G2; Dietary supplement: normal saline N2; Dietary supplement: high-energy digestible food E1; Dietary supplement: glucose injection G1; Dietary supplement: normal saline N1

Detailed Description

This study is a prospective randomized controlled study to investigate the gastric emptying time of high energy digestible foods in delivery women, and the effect of high energy digestible food given before surgery on the comfort and metabolism of women undergoing Cesarean section.

In the first step, 60 women in delivery room are enrolled, who are full term singleton pregnancy subjects ranging 18 to 50 years old and fasting for more than 8 hours. They are randomly divided into three groups, 20 cases in each group.

The experimental group (Group E1) is treated with high energy digestible food 300ml, Group G1 is given 5% glucose injection 300ml and Group N1 is given normal saline 300ml. The gastric volume was determined by gastric antrum cross-sectional area (CSA) measured with ultrasonography before drinking and once every hour after drinking. Once CSA is less than 3.81 cm2, the time is recorded as gastric emptying time of the woman. The overall gastric emptying time of high energy digestible food is determined with the 90 percentile gastric emptying time of women drinking high energy digestible food.

The second step was to recruit 80 cases of full-term elective cesarean section. They were randomly divided into four groups, 20 cases in each group. The experimental group (Group E2) was given high energy digestible food 300ml before the time of gastric emptying found in the first step, Group G2 is given 5% glucose injection 300ml and Group N2 is given normal saline 300ml, while the control group (Group C2) was not given any diet. After admission to the operation room, the volume of the stomach was measured by ultrasound, and the differences of comfort, body temperature, shivering, blood glucose and postoperative anal exhaust time between the two groups were observed.

This study is going to investigate the gastric emptying time of high energy digestible foods in delivery women, and the effect of high energy digestible food on the comfort, body temperature and blood glucose of women undergoing Cesarean section, so as to provide a good basis for reducing the surgery stress in women undergoing Cesarean section.

• Study Type: Interventional
• Enrollment (Anticipated): 140
• Phase: Not Applicable

Contacts and Locations

Study Locations

• China
  • Shanghai
    • Shanghai, Shanghai, China
      • Recruiting
      • Shanghai First Maternity and Infant Hospital, affiliated to Tongji University
      • Contact: Qiwei Wu; Phone Number: 13564621298; Email: 13564621298@163.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 50 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• ASA (American Society of Anesthesiologist) grade II, full term singleton pregnancy subjects aged 18 to 50 years old;
• subjects undergoing elective cesarean section under combined spinal epidural anesthesia;
• volunteered to participate in the study and signed informed consent.

Exclusion Criteria:

• related drug allergies or taboo;
• Severe cardiopulmonary disorders (New York Heart Association Classification III-IV, or left ventricular ejection fraction < 30%) and liver and kidney dysfunction (alanine aminotransferase exceeding the upper limit of normal value twice, creatinine exceeding the upper limit of normal value 1.5 times), alcoholism history;
• there are metabolic diseases such as gestational diabetes mellitus, or using drugs that affect metabolism;
• the subjects were unable to cooperate or to communicate;
• the subjects suffered from psychosocial diseases;
• participated in other clinical trials within one month;
• there is drug abuse.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Triple

Number of Arms

7

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: High energy 2; In the second step, the experimental group (Group E2) was given high energy digestible food 300ml before the time of gastric emptying found in the first step before surgery.	Dietary supplement: high-energy digestible food E2; The women undergoing Cesarean section are given high energy digestible food 300ml before surgery; Other Names: E2
Active Comparator: Glucose 2; In the second step, Group G2 is given 5% glucose injection 300ml before the time of gastric emptying found in the first step before surgery.	Dietary supplement: glucose injection G2; The women undergoing Cesarean section are given glucose injection 300ml before surgery; Other Names: G2
Placebo Comparator: Normal saline 2; In the second step, Group N2 is given normal saline 300ml before the time of gastric emptying found in the first step before surgery.	Dietary supplement: normal saline N2; The women undergoing Cesarean section are given normal saline 300ml before surgery; Other Names: N2
No Intervention: Control 2; In the second step, the control group (Group C2) was not given any diet before surgery.
Experimental: High energy 1; In the first step,The experimental group (Group E1) is treated with high energy digestible food 300ml.	Dietary supplement: high-energy digestible food E1; The women in delivery room are given high energy digestible food 300ml.; Other Names: E1
Active Comparator: Glucose1; In the first step, Group G1 is given 5% glucose injection 300ml	Dietary supplement: glucose injection G1; The women in delivery room are given glucose injection 300ml.; Other Names: G1
Placebo Comparator: Normal saline 1; In the first step, Group N1 is given normal saline 300ml.	Dietary supplement: normal saline N1; The women in delivery room are given normal saline 300ml.; Other Names: N1

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
body temperature	Maternal tympanic temperature measured by infrared ear thermometer	the time point when newborn delivers and 1 hour after surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Maternal comfort	Maternal comfort is measured by the women undergoing Cesarean section with visual analogy scale. Respondents mark the location on the 10-centimeter line corresponding to the amount of comfort they experienced.	up to 24 hours after surgery
Incidence and severity of shivering	Incidence and severity of shivering is assessed with Wrench's Grade.	up to 1 hour after surgery
nausea and vomitting after surgery	The severity of postoperative nausea and vomitting is assessed with CTCAE v4.0.	up to 24 hours after surgery
flatus time	The time point when anal exhaust restarts after surgery	up to 48 hours after surgery
pain after surgery	Maternal pain is measured by the women undergoing Cesarean section with visual analogy scale. Respondents mark the location on the 10-centimeter line corresponding to the amount of pain they experienced.	up to 48 hours after surgery

Collaborators and Investigators

• Sponsor: Shanghai First Maternity and Infant Hospital

Study record dates

Study Major Dates

• Study Start (Anticipated): December 1, 2018
• Primary Completion (Anticipated): August 31, 2019
• Study Completion (Anticipated): December 31, 2019

Study Registration Dates

• First Submitted: November 4, 2018
• First Submitted That Met QC Criteria: November 16, 2018
• First Posted (Actual): November 20, 2018

Study Record Updates

• Last Update Posted (Actual): November 20, 2018
• Last Update Submitted That Met QC Criteria: November 16, 2018
• Last Verified: November 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: ERAS obstetric

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No